NCT05377099 is a NA clinical trial of CORVIS in Corneal Biomechanics, sponsored by Cairo University.

Who is sponsoring NCT05377099?

NCT05377099 is sponsored by Cairo University.

What drugs are being tested in NCT05377099?

Interventions in NCT05377099: CORVIS.

What condition does NCT05377099 study?

NCT05377099 studies Corneal Biomechanics.

Is NCT05377099 still recruiting?

NCT05377099 is currently completed. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT05377099

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Change in the DA Ratio, IR and SSI as Parameters of Corneal Biomechanics Post Different LVC Procedures

Completed NA Last updated 21 February 2023

What this trial tests

NA trial testing CORVIS in Corneal Biomechanics in 33 participants. Completed in 30 January 2023.

Timeline

1 January 2022

Primary endpoint
1 August 2022

30 January 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	33
Start date	1 January 2022
Primary completion	1 August 2022
Estimated completion	30 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

CORVIS

Conditions studied

Corneal Biomechanics — all drugs for Corneal Biomechanics →

Sponsor

Cairo University

Who can join

Adults 18 to 40, any sex, with Corneal Biomechanics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the study, The Investigators will compare the participates' corneal biomechanical properties including: Deformation Amplitude ratio (Da Ratio) Integrated Radius (IR) Stress strain index (SSI) All measurements will be taken before and after 3 months of LVC.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05377099 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05377099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing